New Cancer Treatment Combo Dramatically Improves Lung Cancer Surgery Outcomes
Combining chemotherapy with immunotherapy before surgery significantly increases complete response rates in early-stage lung cancer patients.
396 articles in this topic
Combining chemotherapy with immunotherapy before surgery significantly increases complete response rates in early-stage lung cancer patients.
Scientists discover ALPK1 receptor agonists trigger powerful anti-tumor immunity, offering new immunotherapy approach beyond current treatments.
Breakthrough therapy converts tumor cells into antigen-presenting cells that train immune system to destroy cancer.
New review reveals HPV causes 60-70% of throat cancers in developed countries, with survival rates varying dramatically by cancer type.
Advanced gastric cancer treatments using immunotherapy and targeted drugs extend survival by 3-4 months beyond traditional chemotherapy.
Circulating tumor DNA testing identifies microscopic cancer remnants, predicting recurrence risk with remarkable accuracy.
Liquid biopsy using circulating tumor DNA shows promise for catching gastrointestinal cancer recurrence before symptoms appear.
Revolutionary liquid biopsy technologies show promise for catching GI cancers early through simple blood tests, potentially saving millions of lives.
New blood-based tests could revolutionize pancreatic cancer diagnosis by detecting biomarkers without tissue biopsies.
New research reveals how blocking specific enzymes could dramatically improve cancer immunotherapy effectiveness by removing immune suppression.
New research shows removing cost barriers significantly increases genetic testing uptake among cancer survivors' relatives.
Scientists discover how two microbes team up to accelerate colon cancer, but L-arginine may disrupt their deadly partnership.